Has the neuromuscular junction been over-exposed or is it perhaps already a closed book? I asked myself this at a recent International Congress when an American colleague complained that the Journal of Physiology had articles on nothing but the neuromuscular junction, while another colleague asked why I was editing a volume on a subject about which everything was already known. It is worrying to think that these views may be shared by other people. I hope that this volume will convince my two colleagues and other readers that the neuromuscular junction is very much alive and continues to attract the interest of many workers from a variety of fields; strange as it may seem, the synapse between a motor nerve ending and muscle fibre, with its relatively simple architecture, is one of the most inter� esting sites in the body-I do hope we have done it justice. The various chapters of this volume present a cross section of knowledge as viewed by a group of 13 individuals, actively engaged in research. Multi-author volumes such as this are frequently criticised on the grounds that chapters or sec� tions overlap. I believe that such criticium is only valid where the overlap is repetitious. Where it results in the reader having available discussions of material from differing stand-points, overlap becomes a valuable feature of this type of publication.

Contenuti

Introductory Chapter The Neuromuscular Junction: Areas of Uncertainty.- Neuromuscular Block by Prolonged Depolarisation.- Desensitisation.- The Clinical Picture.- The Presence of Other Drugs.- The Importance of the Drug Structure and that of the Acetylcholine Receptor.- Pre-Synaptic or Post-Synaptic Action?.- Closing Remarks.- References.- 1 The Anatomy and Pathology of the Neuromuscular Junction.- A. Introduction.- B. Normal Muscle.- I. The Motor Unit.- II. Pattern of Innervation and Distribution of Motor End-Plates.- III. The Structure of the Neuromuscular Junction.- 1. Axon Terminals.- 2. Experimental Modifications of the Structure of the Axon Terminal.- 3. Transmitter Release and Synaptic Vesicles.- 4. The Postsynaptic Region.- 5. The Localization of Cholinesterase.- 6. The Basement Membrane.- 7. The Localization of Acetylcholine Receptors.- C. Development, Growth, and Plasticity of the Neuromuscular Junction.- 1. Development of the Neuromuscular Junction.- 2. Development in Tissue Culture.- 3. Structural Denervation.- D. The Neuromuscular Junction in Disorders of Transmission.- 1. Myasthenia Gravis.- 2. The Myasthenic Syndrome.- 3. Hereditary Motor End-Plate Disease in the Mouse.- 4. The Effects of Botulinum Toxin.- 5. The Effects of Tetanus Toxin.- E. The Neuromuscular Junction in Disorders of the Muscle Fibre.- F. Conclusion.- References.- 2 Neurochemistry of Cholinergic Terminals.- A. Introduction.- B. Methods for Extracting and Measuring Acetylcholine.- 1. Preparation of Tissues for Extraction of ACh.- 2. Extraction of ACh.- 3. Assay of ACh.- C. Acetylcholine Synthesis.- 1. Choline Acetyltransferase: its Location and Physical Properties.- 2. Choline Acetyltransferase: its Chemistry, Substrates, and Inhibitors.- 3. Choline Acetyltransferase: its Kinetics.- 4. Supply of Acetyl Groups for ACh Synthesis.- 5. Supply of Choline for ACh Synthesis.- 6. Transport of Choline.- 7. Inhibitors of Choline Transport.- 8. ACh Uptake.- 9. Control of ACh Synthesis.- D. Acetylcholine Storage.- 1. Brain.- 2. Ganglion.- 3. Skeletal Muscle.- 4. Electric Organ.- 5. Other Tissues.- E. Acetylcholine Release.- 1. Correlation of Neurochemical and Electrophysiological Data.- 2. ACh Content: Vesicles vs. Quanta.- 3. Is ACh Released from the Nerve-Terminal Cytoplasm?.- 4. Is Release of ACh Regenerative?.- 5. Calcium and ACh Release.- 6. Neurotoxins and ACh Release.- 7. Drugs and ACh Release.- 8. Cyclic Nucleotides, Prostaglandins and ACh Release.- 9. Contractile Proteins, Microtubules and Microfilaments.- 10. Are Quanta Released by Exocytosis?.- F. Acetylcholine Turnover.- 1. Tissue ACh Turnover during Rest and Activity.- 2. Preferential Release of Newly Synthesized ACh.- 3. ACh Turnover in Relation to Changes in Ultrastructure.- 4. ACh Turnover as Studied by Cell Fractionation Techniques.- 5. Transfer of ACh between Pools or Compartments.- 6. A Tentative Model for ACh Storage and Metabolism.- G. Removal of Acetylcholine.- 1. Enzymatic Destruction.- 2. ACh Uptake.- 3. Diffusion from the Synaptic Cleft.- H. Axonal Transport of Materials Related to Cholinergic Transmission.- 1. Acetylcholinesterase.- 2. Choline Acetyltransferase.- 3. Acetylcholine.- 4. Other Materials.- 5. Effects of Agents that Block Axonal Transport.- 6. A Note on Other Trophic Influences Mediated by Cholinergic Nerves.- I. Prolonged Neurochemical Changes Resulting from Synaptic Activity.- 1. Causes of Synaptic Plasticity.- 2. Post-Tetanic Potentiation.- 3. Enzyme Induction.- 4. Possible Contribution by Glial Elements.- References.- 3 Transmission of Impulses from Nerve to Muscle.- A. Introduction.- B. The Muscle Fibre and the Action of Acetylcholine.- I. Some Relevant Properties of Muscle Fibres.- 1. The Membrane Potential and its Measurement.- 2. Factors Influencing the Membrane Potential.- II. The End-Plate Potential.- 1. Introduction.- 2. General Characteristics of the Permeability Change Caused by the Transmitter.- 3. The Representation of Transmitter Action in Electrical Terms.- 4. The Influence of the Non-Synaptic Membrane on the Response to Acetylcholine.- III. The Ion Selectivity of the Permeability Change Produced by the Transmitter.- 1. The Voltage Clamp Technique.- 2. The End-Plate Current.- 3. Relative Contribution of Different Ions to the Conductance Increase.- 4. Characteristics of the Additional Ion Channels.- 5. Evidence on Ion Selectivity from the Use of Radio-Isotopes.- IV. Localization of Acetylcholine Receptors.- 1. Introduction.- 2. The Ionophoretic Method of Drug Application.- 3. Evidence on Receptor Distribution from Ionophoretic Experiments.- 4. Other Electrophysiological Evidence on the Distribution of Receptors.- 5. Evidence on Receptor Distribution from Experiments with Labelled Antagonists.- 6. Denervated Muscle.- 7. Characteristics of Acetylcholine Receptors in Denervated Muscle.- V. The Interaction between Acetylcholine and its Receptors.- 1. Classical Models of Receptor Action.- 2. The “Allosteric” Model of the Receptor.- 3. New Evidence on Receptor Action: Acetylcholine “Noise”.- 4. The Response to Prolonged Application of Depolarizing Agents.- VI. Modification of Transmitter Action.- 1. Competitive Antagonism.- 2. Evidence for Competition between Curare Alkaloids and Acetylcholine.- 3. Other Agents which Influence Transmitter Action.- C. Pre-Synaptic Events.- I. Introduction.- II. Miniature End-Plate Potentials.- 1. Occurrence.- 2. Amplitudes of Miniature End-Plate Potentials.- 3. Abnormal Miniature End-Plate Potentials.- 4. The Rate of Spontaneous Release.- 5. External Recording of Spontaneous Discharge.- III. Evidence for the Quantal Nature of Evoked Transmitter Release.- 1. Intracellular Recording: Counts of “Failures”.- 2. Evidence from Extracellular Recording: Counts of Quanta.- 3. Amplitude Distribution of Responses.- 4. Variance of the Amplitude Distribution.- 5. Evidence that Fluctuations in Transmitter Release Reflect Variations in the Number of Quanta Released Rather than in the Amount of Transmitter per Quantum during Facilitation and Depression.- 6. Quantal Nature of Transmitter Release Evoked by Presynaptic Depolarization without Action Potentials.- IV. Physical and Statistical Models for Quantal Release.- V. The Calcium Hypothesis.- VI. Estimating Values of the Quantal Content.- 1. Methods.- 2. Estimates of Normal Quantal Contents.- 3. Errors in Quantal Content Estimates in the Presence of Drugs.- VII. Studies on Evoked Release of Transmitter.- 1. Methods of Evoking Release.- 2. Relationship between the Various Methods of Evoking Release.- VIII. Factors Affecting Evoked Transmitter Release.- 1. Calcium and Magnesium.- 2. Non-Specific Factors Affecting Evoked Release.- 3. Agents which Increase Evoked Transmitter Release.- 4. Substances which Reduce Evoked Transmitter Release.- 5. Relationship between Changes in Evoked and Spontaneous Release of Transmitter.- IX. Facilitation and Depression.- 1. Depression and Depletion of Evoked Transmitter Release.- 2. Short Term Facilitation.- 3. Post-Tetanic Potentiation (Presynaptic).- D. Postscript.- References.- 4A Depolarising Neuromuscular Blocking Drugs.- A. General Introduction.- B. An Introduction to the Pharmacological Actions of Decamethonium at the Neuromuscular Junction.- C. End-Plate Depolarisation by Decamethonium and Suxamethonium in vivo.- D. Effect of Decamethonium, Suxamethonium and Acetylcholine on the Electrical Properties of Single Mammalian Muscle Cells.- 1. Membrane Potential.- 2. Input Resistance.- 3. Effect of Acetylcholine on Membrane Potential.- 4. The Effect of Decamethonium in Chloride-Free Solution.- 5. The Effect of Ouabain.- E. Depolarisation Versus Desensitisation.- F. Species Differences and Depolarising Neuromuscular Blocking Drugs.- I. Man and Cat.- II. Other Mammalian Species.- III. Avian Muscle.- G. Factors which May Modify the Action of Depolarising Neuromuscular Blocking Drugs and Variations Due to Experimental Conditions.- I. The Effect of Lowered Muscle Temperature.- II. Tachyphylaxis.- III. “Potentiation” of a Maximal Twitch.- IV. Frequency of Stimulation.- H. Concluding Remarks.- References.- 4B Competitive Neuromuscular Blocking Drugs.- A. Introduction and Terminology.- B. Chemical Structure.- C. Methods Used to Measure Neuromuscular Blockade.- I. Muscle Contractions Evoked by Stimulation of the Motor Nerve.- II. Recording of Muscle Contraction.- 1. Selection of Strain Gauge.- 2. Optimal Muscle Length.- 3. Influence of Temperature.- 4. Correlation between Twitch Size and Receptor Occlusion.- III. Recording of Action Potentials.- IV. Measurements of Membrane Potential.- 1. Extracellular Recording.- 2. Intracellular Microelectrode Recording.- D. Distribution of Competitive Neuromuscular Blocking Drugs.- I. General Properties.- II. Transport of Neuromuscular Blocking Drugs across Cell Membranes.- 1. Entry into Liver Cell and Biotransformation.- 2. Excretion into Bile.- 3. Entry into Muscle Cells.- III. Plasma Protein Binding.- E. Factors Affecting Duration of Action in Animals and Man.- I. Species Variation.- 1. Potency.- 2. Duration of Action.- II. Biotransformation in the Liver.- III. Renal and Biliary Excretion.- IV. Redistribution.- 1. Binding in Extracellular Compartment.- 2. Binding at End-Plate Region.- V. Termination of Action by Chemical Inactivation of the Drug.- F. Mechanism of Action at Neuromuscular Junction.- I. Evidence for Competitive Antagonism in vitro.- II. Evidence for Competitive Antagonism in vivo.- 1. Quantitative Studies.- 2. Qualitative Studies.- III. Factors Affecting Neuromuscular Blocking Action.- 1. Sensitivity of Fast and Slow Fibres.- 2. Effect of Temperature.- 3. Effect of Age.- 4. Effect of Acidosis.- G. Effects at Cholinergic Synapses in the Autonomic Nervous System.- I. Actions on Autonomic Ganglia.- II. Actions on the Heart.- H. Histamine Release in Animals and Man.- J. Miscellaneous Drugs which Cause Muscle Paralysis.- I. General Anaesthetics.- II. Barbiturate and Non-Barbiturate Hypnotic Drugs.- III. Local Anaesthetics.- IV. Antibiotics.- References.- 4C Pharmacology of Anticholinesterase Drugs.- A. Introduction.- B. Morphology and Function of Acetylcholinesterase (AChE).- I. Localization of AChE at the Motor End-Plate.- II. Hydrolysis of ACh.- C. Inhibition of AChE.- I. Kinetics of Inhibition of AChE.- II. Measurements of the in vivo Inhibition of AChE.- D. Actions of Anticholinesterases of the Carbamate and Organophosphate Type and of Anilinium Ions.- I. Twitch Potentiation.- II. Fasciculations.- III. Tetanic Fade.- IV. Anticurare Action.- 1. Anticurare Action at Frequencies of Nerve Stimulation which Normally Produce Twitch Responses.- 2. Anticurare Action at Frequencies of Nerve Stimulation which Normally Produce a Sustained Contraction of Muscles.- V. Reversal of the Symptoms of Myasthenia Gravis.- VI. Selectivity of Action.- VII. Adaptation to Prolonged Inhibition of AChE.- VIII. Antidotal Effects of Tubocurarine and Reactivators of Phosphorylated AChE; Selectivity of Action of Reactivators.- IX. Inhibition of Cholinesterase (ChE).- General Conclusions.- Appendix I Studies on Frog Muscles.- Appendix II Anticholinesterases and Anilinium Ions Referred to in the Text.- Appendix III An Outline of the Methods Used to Calculate the Quantal Content of the e.p.p. and the Rate of Refilling and Size of the ACh Store in Nerve Terminals.- References.- 5A The Clinician Looks at Neuromuscular Blocking Drugs.- A. Introduction.- B. General Anaesthesia before Neuromuscular Blocking Drugs.- C. Clinical Influence of Neuromuscular Blocking Drugs.- D. Three Possibly Fatal Reactions to Suxamethonium.- E. Less Serious Reactions to Suxamethonium.- F. Personal Technique.- G. Conclusions.- References.- 5B Neuromuscular Blocking Drugs in Man.- A. Introduction.- B. Measurement of Drug Action.- I. Voluntary Muscle Contractions.- II. Direct Measurement of Neuromuscular Transmission in Man.- 1. General Aspects.- 2. Electrical Stimulation of Motor Nerves and Stimulus Schedules.- 3. Electromyographic Recording.- 4. Recording of Muscle Contractions.- 5. Experimental Conditions.- 6. Definition of Terms.- III. Quantitation of Neuromuscular Blockade and Assessment of Residual Blockade.- C. Pharmacokinetics of Neuromuscular Blocking Drugs.- I. Distribution and Elimination.- II. Plasma Protein Binding.- III. The Placental and Blood-Brain Barriers.- D. Action of Neuromuscular Blocking Drugs at the Neuromuscular Junction.- I. General Characteristics.- II. Influence of Anaesthetics.- III. Muscle Temperature and Blood Flow.- IV. Carbon Dioxide and Plasma pH.- V. Dual Block.- VI. Responses of Newborn Infants.- VII. Antibiotic Administration.- VIII. Suxamethonium and Muscle Pain.- IX. Suxamethonium and Plasma Cholinesterase.- X. Myopathy.- E. Other Actions of Neuromuscular Blocking Drugs.- I. Histamine Release.- II. Cardiovascular Actions.- III. Suxamethonium and Hyperkalaemia.- IV. Ocular Actions.- References.- 5C Twenty Years’ Experience with Decamethonium.- A. Introduction.- B. First Clinical Reports.- C. Analysis of 32000 Administrations of Decamethonium.- I. Surgical Experience.- II. Analysis.- III. Methods of Administration.- 1. Early Techniques.- 2. Present Techniques.- IV. Complications.- V. Cardiovascular System and Decamethonium.- VI. Muscle Pains and Decamethonium.- D. Assessment.- References.- Author Index.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Descrizione libreria

We specialise in General Interest Books from South Asian countries.

Visita la pagina della libreria

Informazioni sull?azienda del venditore

BOOKS AND PERIODICALS AGENCY LTD
90 Barnet Gate Lane, Barnet, EN5 2AX, United Kingdom

Condizioni di vendita e spedizione

Condizioni di vendita

Returns accepted if you are not satisfied with the Service or Book.

Diritto di recesso

Se sei un consumatore, puoi esercitare il tuo diritto di recesso seguendo le istruzioni riportate di seguito. Per "consumatore" si intende qualsiasi persona fisica che agisca per fini che non rientrano nel quadro della sua attivit� commerciale, industriale, artigianale o professionale.

Informazioni relative al diritto di recesso

Diritto di recesso

Hai il diritto di recedere dal presente contratto, senza indicarne le ragioni, entro 14 giorni.

Il periodo di recesso scade dopo 14 giorni dal giorno in cui

tu acquisisci, o un terzo designato diverso dal vettore e da te acquisisce, il possesso fisico dell'ultimo bene o l'ultimo lotto o pezzo.

Per esercitare il diritto di recesso, sei tenuto a informare Majestic Books, 315 Chiswick High Road, W4 4HH, London, ,, United Kingdom, +44 02085704746, della tua decisione di recedere dal presente contratto tramite una dichiarazione esplicita (ad esempio lettera inviata per posta, fax o posta elettronica). A tal fine puoi utilizzare il modulo tipo di recesso, ma non e' obbligatorio. Puoi anche compilare e inviare elettronicamente il modulo tipo di recesso o qualsiasi altra esplicita dichiarazione sul nostro sito web, dalla sezione "Ordini" nel "Mio Account". Nel caso scegliessi questa opzione, ti trasmetteremo senza indugio una conferma di ricevimento su un supporto durevole (ad esempio per posta elettronica).

Per rispettare il termine di recesso, � sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso.

Effetti del recesso

Se recedi dal presente contratto, ti saranno rimborsati tutti i pagamenti che hai effettuato a nostro favore, compresi i costi di consegna (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di consegna diverso dal tipo meno costoso di consegna standard da noi offerto). Potremo trattenere dal rimborso le somme derivanti da una diminuzione del valore del prodotto risultante da una tua non necessaria manipolazione.

I rimborsi verranno effettuati senza indebito ritardo e in ogni caso non oltre 14 giorni dal giorno in cui siamo stati informati della tua decisione di recedere dal presente contratto.

Detti rimborsi saranno effettuati utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente convenuto altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso. Il rimborso pu� essere sospeso fino al ricevimento dei beni oppure fino all'avvenuta dimostrazione da parte tua di aver rispedito i beni, se precedente.

Ti preghiamo di rispedire i beni o di consegnarli a Majestic Books, 315 Chiswick High Road, W4 4HH, London, ,, United Kingdom, +44 02085704746, senza indebiti ritardi e in ogni caso entro 14 giorni dal giorno in cui hai comunicato il tuo recesso dal presente contratto. Il termine � rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione del bene diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni.

Eccezioni al diritto di recesso

Il diritto di recesso non si applica in caso di:

fornitura di giornali, periodici e riviste ad eccezione dei contratti di abbonamento per la fornitura di tali pubblicazioni;
fornitura di contenuto digitale (inclusi applicazioni, software, ebook, MP3, ecc.) mediante un supporto non materiale (per esempio un CD o un DVD) se al momento dell'inoltro dell'ordine hai espressamente consentito all'inizio dell'esecuzione accettando la perdita del diritto di recesso in conseguenza dell'inizio di esecuzione.

Modulo di recesso tipo

(Compilare e restituire il presente modulo solo se si desidera recedere dal contratto)

Destinatario: (Majestic Books, 315 Chiswick High Road, W4 4HH, London, ,, United Kingdom, +44 02085704746)

Con la presente io/noi (*) notifichiamo il recesso dal mio/nostro (*) contratto di vendita dei seguenti beni/servizi (*)

Ordinato il (*) /ricevuto il (*)

Nome del/dei consumatore(i)

Indirizzo del/dei consumatore(i)

Firma del/dei consumatore(i) (solo se il presente modulo � notificato in versione cartacea)

Data

(*) Cancellare la dicitura inutile.

Condizioni di spedizione

Best packaging and fast delivery

Tariffe di spedizione da Regno Unito a U.S.A.

Tariffe di spedizione da Regno Unito a U.S.A.
Quantit� dell?ordine	Da 14 a 45 giorni lavorativi	Da 5 a 10 giorni lavorativi
Primo articolo	EUR 7.45	EUR 11.29

I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.